Literature DB >> 2716620

The incidence of malignant mesothelioma in Australia, 1947-1980.

A W Musk1, P J Dolin, B K Armstrong, J M Ford, N H de Klerk, M S Hobbs.   

Abstract

Details of patients with malignant mesothelioma that was diagnosed in Australia before 1981 were obtained by searching all possible sources throughout Australia as far into the past as possible and up to and including 1980. The earliest patient with mesothelioma who was identified was diagnosed in Victoria in 1947. By 1980, 535 (81%) men and 123 (19%) women had been diagnosed with the disease; only 14 persons were aged less than 35 years at the time of diagnosis (the youngest person was 15 years of age). The incidence rate in subjects who were 35 years or older at diagnosis was less than 1.0 cases per million person-years until 1964-1968, and then it rose progressively to 15.5 cases per million person-years in 1979-1980. The highest rate (69.7 cases per million person-years) was observed in 65- to 74-year-old men in 1979-1980. The incidence rate in Western Australia was greater than were the rates in other states of Australia after the mid 1960s. Pleural mesotheliomas accounted for 88% of cases in which the site of the tumour was known; peritoneal mesotheliomas accounted for 10% of such cases and "other" sites for 2% of such cases. In 6% of cases the site was not specified. The exposure to asbestos was stated as "definite" in 59% of the cases with a recorded history of exposure: 8% of all the cases in the study had been exposed to crocidolite (blue asbestos) from Wittenoom Gorge in Western Australia. The age at diagnosis of patients with known exposure to asbestos was similar to that in those without known exposure. The increases in the incidence of malignant mesothelioma in Australia follow the published trends in the production and use of the amphibole varieties of asbestos in this country after a lag period of between 20 and 30 years.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2716620

Source DB:  PubMed          Journal:  Med J Aust        ISSN: 0025-729X            Impact factor:   7.738


  9 in total

Review 1.  Malignant mesothelioma: facts, myths, and hypotheses.

Authors:  Michele Carbone; Bevan H Ly; Ronald F Dodson; Ian Pagano; Paul T Morris; Umran A Dogan; Adi F Gazdar; Harvey I Pass; Haining Yang
Journal:  J Cell Physiol       Date:  2012-01       Impact factor: 6.384

2.  Pleural lesions in crocidolite workers from Western Australia.

Authors:  G Hillerdal; A W Musk
Journal:  Br J Ind Med       Date:  1990-11

3.  Effect of an Indwelling Pleural Catheter vs Talc Pleurodesis on Hospitalization Days in Patients With Malignant Pleural Effusion: The AMPLE Randomized Clinical Trial.

Authors:  Rajesh Thomas; Edward T H Fysh; Nicola A Smith; Pyng Lee; Benjamin C H Kwan; Elaine Yap; Fiona C Horwood; Francesco Piccolo; David C L Lam; Luke A Garske; Ranjan Shrestha; Christopher Kosky; Catherine A Read; Kevin Murray; Y C Gary Lee
Journal:  JAMA       Date:  2017-11-21       Impact factor: 56.272

4.  Intestinal obstruction due to diffuse peritoneal fibrosis at 2 years after the successful treatment of malignant peritoneal mesothelioma with intraperitoneal mitoxantrone.

Authors:  L T Vlasveld; B G Taal; B B Kroon; M P Gallee; S Rodenhuis
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

5.  Lymphangitis carcinomatosa complicating primary malignant peritoneal mesothelioma.

Authors:  P S Craft; M S Reading; S Jain; R A O'Neil
Journal:  Thorax       Date:  1996-05       Impact factor: 9.139

6.  Successful immunochemotherapy for patients with malignant mesothelioma: report of two cases.

Authors:  M Tani; H Tanimura; H Yamaue; S Mizobata; M Yamamoto; M Iwahashi; K Ura; Y Nagai; T Tsunoda; H Wakasaki; K Nanjo; K Fujino; S Yukawa
Journal:  Surg Today       Date:  1998       Impact factor: 2.549

7.  Malignant mesothelioma: attributable risk of asbestos exposure.

Authors:  R Spirtas; E F Heineman; L Bernstein; G W Beebe; R J Keehn; A Stark; B L Harlow; J Benichou
Journal:  Occup Environ Med       Date:  1994-12       Impact factor: 4.402

Review 8.  Nonpulmonary outcomes of asbestos exposure.

Authors:  Melisa Bunderson-Schelvan; Jean C Pfau; Robert Crouch; Andrij Holian
Journal:  J Toxicol Environ Health B Crit Rev       Date:  2011       Impact factor: 6.393

9.  An Overview of Asbestos and Malignant Pleural Mesothelioma: An Iranian Perspective

Authors:  Habib Emami; Alireza Ilbeigi; Kian Khodadad
Journal:  Asian Pac J Cancer Prev       Date:  2017-10-26
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.